Akizone S 250mg/125mg Injection
Marketer
Akiez Healthcare
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Akizone S 250mg/125mg Injection
Combiflox 250mg/125mg Injection is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism inhibits microbial growth, thereby halting infection progression. Administration of Combiflox 250mg/125mg Injection must be under strict medical guidance. Consistent adherence to the prescribed dosage is crucial; prematurely halting treatment may compromise its efficacy. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical attention. Seek immediate emergency care for allergic reactions such as skin rashes, itching, swelling, or respiratory distress. Prior to commencing treatment, inform your physician of all current medications and pre-existing conditions. Pregnant or lactating individuals require specific medical consultation before use. Alcohol consumption should be avoided due to the potential for increased drowsiness. While generally not impairing driving ability, avoid operating vehicles if drowsiness or dizziness occur. Sufficient rest, a nutritious diet, and ample hydration are recommended for optimal recovery. Your doctor may order blood tests and other examinations to monitor the medicine's effects.
Uses of Akizone S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Akizone S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Akizone S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Akizone S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Akizone S 250mg/125mg Injection works:
Akizone S Injection, containing 250mg Ceftriaxone and 125mg Sulbactam, utilizes a dual-action approach to combat bacterial infection. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. The addition of Sulbactam, a beta-lactamase inhibitor, overcomes bacterial resistance mechanisms, thus optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Akizone S 250mg/125mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Akizone S (250mg/125mg) is usually deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harm to fetuses; nevertheless, clinical data from human trials are scarce.
Breast feedingCAUTION
Administering Akizone S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Akizone S 250mg/125mg Injection can lead to reduced attentiveness, visual disturbances, drowsiness, and dizziness. Driving should be avoided if any of these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Akizone S 250mg/125mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Individuals with severe hepatic impairment should exercise caution when using Akizone S 250mg/125mg Injection, as dosage modification may be necessary. Seek medical advice before administering. Dosage alteration of Akizone S 250mg/125mg Injection is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Akizone S 250mg/125mg Injection :
Omit a dose of Akizone S 250mg/125mg Injection? Seek your physician's advice.
Facts to Know About Akizone S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |
3,018 People bought this recently